OptimizeRx Corp — Director's Dealing 2016

Jul 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2016-07-13

Reporting Person: Hamilton Terrence (VP OF SALES)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-13	Right to Shares of Common Stock	$0	J	384188	Disposed	2016-07-13	Common Stock (384188)	Direct

Footnotes

F1: The Issuer paid the Reporting Person $449,500 as a payout for 384,188 shares of common stock owed, but unissued, to the Reporting Person.